<DOC>
	<DOCNO>NCT00482599</DOCNO>
	<brief_summary>The purpose study compare efficacy pharmacokinetics Org 25969 subject normal impaired renal function evaluate safety Org 25969 subject impaired renal function .</brief_summary>
	<brief_title>Efficacy , Pharmacokinetics Safety Org 25969 Subjects With Normal Impaired Renal Function ( 19.4.304 ) ( P05948 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>ASA class 1 3 renally impaired patient , ASA class 12 control group Age least 18 year Scheduled general anesthesia without need muscle relaxation one single dose 0.6 mg.kg1 rocuronium Scheduled surgical procedure supine position Written inform consent Creatinine clearance ( CLCR ) &lt; 30 mL/min renally impaired group , CLCR = 80 mL/min control group Known suspect neuromuscular disorder impair NMB Known suspect ( family ) history malignant hyperthermia Known suspect allergy narcotic , muscle relaxant medication use general anesthesia Use medication know interfere NMBA base dose time administration , antibiotic , anticonvulsant Mg2+ Pregnancy Childbearing potential without use follow method birth control : condom diaphragm spermicide , vasectomized partner ( &gt; 6 month ) , intrauterine device , abstinence Breastfeeding Prior participation trial Org 25969 Participation another clinical trial , preapproved NV Organon , within 30 day enter trial 19.4.304 , UK : Participation another clinical trial , within 30 day enter trial 19.4.304 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>